SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-10-024321
Filing Date
2010-05-04
Accepted
2010-05-04 17:14:01
Documents
4
Period of Report
2010-05-04

Document Format Files

Seq Description Document Type Size
1 v183361_pre14a.htm PRE 14A 594779
2 GRAPHIC proxyx1x1.jpg GRAPHIC 73888
3 GRAPHIC proxyx2x1.jpg GRAPHIC 61051
4 filename4.htm CORRESP 8839
  Complete submission text file 0001144204-10-024321.txt   791328
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: PRE 14A | Act: 34 | File No.: 000-25169 | Film No.: 10798084
SIC: 2834 Pharmaceutical Preparations